nivolumab,ipilimumab
ono Pharmaceuticals,BMS,ono Pharmaceuticals,BMS
['start,(-starti),(-starte)', 'nivo', 'checkmate 358', 'ipilimumab', 'nivolumab']
great way to start the morning on saturday the 10th of september at #esmo22 with from , discussing safety and efficacy of nivolumab ipilimumab in patients with recurrent/metastatic cervical cancer in checkmate 358 study #cervicalcancer
PLOS ONE is an international, peer-reviewed, open-access, online science publication.